The Global Risks Forum (GRF)

R-P04 · TOPIC · vaccine-and-medical-supply-gGRF dossier · service level R0

GRFHealth and Biosecurity GovernanceIn development

Topic dossier · Health and Biosecurity Governance

Vaccine and medical supply governance

In a health emergency, vaccines, diagnostics, therapeutics and protective equipment must be developed, approved, made and delivered at speed. Manufacturing is concentrated in a few countries, and allocation becomes a political contest. This page sets out how medical countermeasure governance works and where it fails, the records that show access and supply, and who decides.

Make an enquiry Back to Topics

Systems · around this subjectDesign, not a record

Countermeasure supply governance

Vaccine and medical supply governance · Supply coordination cell · Quarter 3

Agreements under reviewGRF · Health and Biosecurity Governance

Countermeasures


Antivirals	11	In place	Priority groups
Diagnostics	2	Renewing	By positivity
Protective equipment	14	In place	By facility tier

Allocation principle

Basis: need and risk
Equity check: Done
Decision: Ministry of health
Record: published

Countermeasure supply governance: the screen's structure, terms and states for Vaccine and medical supply governance.Placeholder names and illustrative values; a design, not a record or a live system.

Fig.Countermeasure supply governance. Design wireframe with placeholder names and illustrative values, not a record or a live system.

01In brief

The short answer.

Vaccine and medical supply governance is the set of rules and institutions that decide how vaccines, diagnostics, therapeutics and protective equipment are approved, made, bought and allocated in emergencies. Concentrated manufacturing, advance purchases and regulatory capacity shape access. Regulators, health ministries and pooled mechanisms hold the decisions.

02Geography

Environmental exposure in Southern Africa.

The interactive map needs JavaScript; the layer list and sources are below.

Layers 3

Environmental exposure, for this page

Latest available

NASA GIBS / EOSDIS · ASTER GDEM (METI, NASA) · Blue Marble (NASA) · © OpenStreetMap contributors (ODbL) · Natural Earth

Loading the latest NASA imagery.

Drag to move. Ctrl or ⌘ and scroll, pinch or the buttons to zoom; hover for the values under the pointer; reset returns to the region.

For vaccine and medical supply governance, in GRF's situational-awareness reading, the map opens on population density, flood water and night lights with nitrogen dioxide from NASA GIBS, framed on Southern Africa; 3 further NASA layers wait in the list.Satellite and model products as NASA publishes them, each with its own date; indicators, not assessments of any place; claim ceiling INTEGRATED.

Data: NASA GIBS · ASTER GDEM · Blue Marble · © OpenStreetMap contributors · Natural Earth · GDACS · ESA Copernicus Sentinel-5P TROPOMI · NASA EONETSources and licences

We acknowledge the use of imagery provided by services from NASA's Global Imagery Browse Services (GIBS), part of NASA's Earth Science Data and Information System (ESDIS). Colours redrawn from the published colour map; values averaged into H3 cells where shown (modified). NASA open data
We acknowledge the use of imagery provided by services from NASA's Global Imagery Browse Services (GIBS), part of NASA's Earth Science Data and Information System (ESDIS). Colours redrawn from the published colour map; values averaged into H3 cells where shown (modified). NASA open data
Center for International Earth Science Information Network (CIESIN), Columbia University. 2018. Gridded Population of the World, Version 4 (GPWv4): Population Density, Revision 11. NASA Socioeconomic Data and Applications Center (SEDAC). Licensed under CC BY 4.0. Colours redrawn from the published colour map; values averaged into H3 cells where shown (modified). CC BY 4.0
VIIRS near-real-time products (flood, land surface temperature, snow cover, corrected reflectance), NASA LANCE; imagery via NASA GIBS. Colours redrawn from the published colour map; values averaged into H3 cells where shown (modified). NASA open data
VIIRS Black Marble night-time lights, NASA Goddard Space Flight Center; distributed by the NASA Level-1 and Atmosphere Archive and Distribution System (LAADS DAAC); imagery via NASA GIBS. Colours redrawn from the published colour map; values averaged into H3 cells where shown (modified). NASA open data
NASA Fire Information for Resource Management System (FIRMS), VIIRS 375 m active fire product, NASA LANCE; vector tiles via NASA GIBS. Colours redrawn from the published colour map; values averaged into H3 cells where shown (modified). NASA open data
MODIS and VIIRS atmosphere products, NASA LANCE and LAADS DAAC; imagery via NASA GIBS. Colours redrawn from the published colour map; values averaged into H3 cells where shown (modified). NASA open data
ASTER GDEM is a product of METI and NASA (ASTER Global Digital Elevation Model V003, NASA LP DAAC); imagery via NASA GIBS. Colours redrawn from the published colour map; values averaged into H3 cells where shown (modified). NASA open data
Made with Natural Earth. Free vector and raster map data @ naturalearthdata.com. Public domain
© OpenStreetMap contributors (ODbL), via NASA GIBS (coastlines, boundaries, roads and place names). Colours redrawn from the published colour map; values averaged into H3 cells where shown (modified). ODbL
Blue Marble, NASA Earth Observatory; imagery via NASA GIBS. Colours redrawn from the published colour map; values averaged into H3 cells where shown (modified). NASA open data
Context on the globe and flat map: coastlines, boundaries, roads and place names from NASA GIBS reference layers (OpenStreetMap data, ODbL, © OpenStreetMap contributors); Blue Marble imagery as an optional base; 3D terrain and the elevation read-out from the ASTER GDEM elevation colour index (5 m to 200 m classes, exaggerated for legibility). Boundaries are drawn as published and imply no position on any territory.
Globe: MapLibre GL JS 6.9.1, BSD-3-Clause, © MapLibre contributors.
Live: GDACS (EC JRC / UN OCHA) Events are indicative, not official warnings.
Observed (EO): ESA Copernicus Sentinel-5P TROPOMI (contains modified Copernicus Sentinel data 2026). We acknowledge the use of imagery provided by services from NASA's Global Imagery Browse Services (GIBS), part of NASA's Earth Science Data and Information System (ESDIS).
Live: NASA EONET Events are indicative, not official warnings.
Optional layers (14 sources in the layer list: live, forecast, observed and context) print their provider credit on the map and here when switched on; forecasts are model output and derived indices are estimates.

Layers and dates

Population density, 2020: Population: CIESIN, Columbia University, Gridded Population of the World v4.11 (2018), NASA SEDAC, CC BY 4.0 · static
Flood water, 3-day composite: VIIRS Global Flood Product, NASA LANCE · 14 Oct 2026
Night-time lights, daily: VIIRS Black Marble (VNP46A2), NASA LAADS DAAC · 12 Oct 2026
Active fires and thermal anomalies, last day: VIIRS NOAA-20 375 m (FIRMS), NASA LANCE FIRMS · 13 Oct 2026
Land surface temperature, day, 8-day composite: VIIRS NOAA-20 Level 3, 8-day, NASA LANCE · 14 Sep 2026
Aerosol optical depth, daily: VIIRS NOAA-20 Deep Blue AOD, NASA LANCE · 13 Oct 2026

03The question

Vaccine and medical supply governance: how the risk develops.

Access, procurement authority and resilience. The dossier below sets out how the risk develops, what is measured, where the data come from, how it is modelled and who decides.

Mechanism

Manufacturing is concentrated

A few countries and firms produce most vaccines and key inputs. Export restrictions and advance purchases by wealthy states leave others waiting.

Mechanism

Regulatory capacity sets pace

Countries without mature regulators rely on WHO prequalification or reliance pathways. Duplicated reviews and unclear emergency use rules delay access.

Mechanism

Advance purchase decides allocation

Contracts signed before products exist reserve supply for those who can pay and bear risk. Pooled mechanisms depend on donors and on manufacturers honouring commitments.

Mechanism

Last mile limits delivery

Cold chain, workforce and demand decide whether doses become vaccinations. Supply without delivery capacity leads to expiry and waste.

04Key terms

Terms used on this page.

Each term as this page uses it. Where a standard-setting body defines the term, the wording follows that body.

Term	Definition
WHO prequalification	WHO's assessment of health products against quality, safety and efficacy standards, used to guide UN and national procurement.
Regulatory reliance	A regulator taking account of a trusted regulator's assessment when reaching its own decision.
Advance purchase agreement	A contract to buy a product before it is approved, reserving supply in exchange for funding or risk-sharing.

05Indicators

What is measured, and how well.

Each indicator carries its unit, its cadence, the kind of source behind it and the evidence label a value would carry. No values are shown: a programme supplies them under its own authority.

Indicator	Unit	Cadence	Source type	Label
Regulatory system maturity level	WHO Global Benchmarking maturity level	on assessment	WHO records	OFFICIAL
Vaccine doses delivered per population	doses per hundred people	monthly in emergencies	WHO and UNICEF dashboards	REPORTED
Time from first approval to first delivery by income group	days	per product	Market and regulatory records	ESTIMATED
Regional manufacturing capacity	doses per year	periodic	Industry and agency surveys	REPORTED
Export restrictions on medical goods	count of measures	during emergencies	Trade monitoring	REPORTED
Doses expired before use	count	per campaign	Programme records	REPORTED

06Canvas

From sources to decisions.

The topic as a computational graph: named sources feed the methods, an evidence review gates the outputs, and the decisions stay with the authorities that hold them.

Pipeline canvas · Vaccine and medical supply governance as a run graphDesign, not a record

Fig. 02Nodes carry their type, two metric rows and a state; connectors show what feeds what; dashed frames name the owners; the timeline is the cadence. Design of the pipeline, not a record of a run.

07Sources

Where the evidence comes from.

Named public datasets and institutional records, each with its licence class. Sources by agreement are used only under their terms and never republished.

Source	What it gives	Licence class
WHO Prequalification and Global Benchmarking Tool records	Prequalified products and regulator maturity levels	Free, WHO terms
UNICEF Supply Division market dashboards	Vaccine supply, prices and deliveries	Free to read, UNICEF terms
Gavi and COVAX records	Allocation and delivery of vaccines	Free to read, terms to check
WTO trade monitoring on medical goods	Trade measures affecting medical products	Free, WTO terms
African Medicines Agency and regional regulatory records	Regional regulatory cooperation	Public records, terms per agency

08Decisions

Who decides, and what the evidence serves.

Health and Biosecurity Governance prepares evidence. The decisions below are taken by the authorities named, under their own rules, and never by the platform.

Who decides	The question	Evidence this page serves
National regulatory authorities	Whether and how to authorise products in an emergency	Reliance pathways and comparable decisions
Health ministries and procurement agencies	What to buy, when and through which mechanism	Supply, price and delivery records
Governments of manufacturing countries	Whether to restrict exports or share supply	Trade measure records and their effects
Boards of Gavi, CEPI and similar bodies	How to allocate funds and doses	Allocation records and evaluations

Outputs this topic produces

Comparative notes on allocation mechanisms in past emergencies
Guide to regulatory reliance and prequalification
Dialogue briefs on regional manufacturing
Questions for governments on advance purchase and sharing commitments

09Core questions

What experts ask.

The questions concern access, authority and resilience.

Who has authority to purchase and allocate countermeasures, nationally and through regional or international mechanisms?
How are allocation priorities set, and are they transparent and fair?
How do export restrictions and advance purchase agreements affect access for others?
How is regulatory authorization coordinated across countries in emergencies?
Where is manufacturing capacity located, and how can it be diversified?

10Mechanisms

Mechanisms and drivers.

Manufacturing capacity for vaccines and many medicines is concentrated in a limited number of countries and firms. In emergencies, countries with purchasing power and domestic production can secure supply first, while others wait. Pooled procurement and regional manufacturing are among the responses to this inequity.

Regulatory processes determine how quickly products reach people. Reliance on assessments by trusted regulators and emergency procedures can speed access but require trust and capacity. Allocation frameworks must balance health need, risk of exposure, protection of health workers and equity.

11Methods and data

How it is studied, and where the methods stop.

Method or data	What it shows	Limits
Procurement and contract analysis	Terms of purchase and supply	Many contracts are confidential
Allocation framework comparison	How priorities are set	Implementation may differ from frameworks
Supply-chain mapping	Concentration and dependencies	Firm-level data is limited
Regulatory reliance analysis	How regulators cooperate	Practices are changing

12Methods

How it is studied, and what the methods cannot say.

13Questions

Questions and answers.

What is WHO prequalification?

A WHO assessment of medicines, vaccines and diagnostics against quality, safety and efficacy standards, used by UN agencies and many countries to guide procurement.

What is regulatory reliance?

When a regulator takes account of another trusted regulator's assessment in reaching its own decision, saving time without giving up its authority.

Why did vaccine access differ between countries?

Because of advance purchase agreements, concentrated manufacturing, export restrictions, regulatory capacity and delivery systems, each documented in reviews of the COVID-19 response.

Why were countermeasures distributed unequally in past emergencies?

Mainly because manufacturing was concentrated and countries with purchasing power secured supply in advance, while allocation mechanisms for others were under-resourced.

What is pooled procurement?

An arrangement in which several countries or purchasers buy together, which can improve bargaining power, reduce prices and widen access for smaller buyers. It requires agreement on governance, financing, product specifications and how supplies are allocated among participants when demand exceeds supply.

Does the platform procure or allocate medical supplies?

No. GRF does not finance or procure. The platform convenes institutions and publishes governance analysis.

Around Health and Biosecurity Governance.

Health and Biosecurity Governance

Bring your expertise to this field.

The current service level is R0: information and enquiries. An enquiry receives a reference and names the next step; applications, payments, compute allocations and registrations open only when their team, terms and review capacity exist.

Write to the team See all contact routes